in conclusion, as a result of its unique property of regulating the estrogen free fraction and cross-talking with the estradiol pathways, by inhibiting estradiol-induced breast cancer cell growth and proliferation, shbg is associated with a reduced risk of developing the neoplasm after estrogen exposure.